#98, Advancing Adaptive Clinical Trials with Causal ML, with Raviv Pryluk from PhaseV
Listen now
Description
PhaseV is pioneering the use of reinforcement learning, causal ML, and adaptive trial design to optimize resource utilization and time efficiency in drug development.
More Episodes
Sword Health's AI-powered platform offers remote monitoring, virtual PT sessions, behavioral health support, and personalized care plans for treating chronic pain.
Published 11/06/24
Published 11/06/24
Rune Labs leverages real-world data and digital biomarkers to revolutionize the treatment of neurodegenerative diseases like Parkinson's, enabling personalized and data-driven care.
Published 10/30/24